EW Jan 2025 77.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Investors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
- Zacks
The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.
- Business Wire
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*
© 2024 Yahoo. All rights reserved.